Lin Clark
Internal Medicine · Tucson, AZNPI 1396830477
Payments from drug & device makers
Across 139 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$279
- Abbott$272
- Merck$203
- Amgen$168
- AbbVie$161
- Biohaven Pharmaceuticals, Inc.$154
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,33699%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $279 |
| Abbott | 2 | $272 |
| Merck | 13 | $203 |
| Amgen | 10 | $168 |
| AbbVie | 15 | $161 |
| Biohaven Pharmaceuticals, Inc. | 5 | $154 |
| Boehringer Ingelheim | 2 | $132 |
| Mylan Specialty L.p. | 8 | $113 |
| Kowa Pharmaceuticals America, Inc. | 9 | $110 |
| Lilly USA, LLC | 7 | $93 |
| Eisai Inc. | 5 | $88 |
| AstraZeneca | 6 | $76 |
| Johnson & Johnson | 5 | $67 |
| Amarin Pharma, Inc. | 3 | $56 |
| Novartis | 3 | $47 |
| Pfizer | 3 | $44 |
| GSK | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Astellas Pharma US Inc | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre$147
- FreeStyle Libre 2$126
- JARDIANCE$117
How this compares
$2,350 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $145,204 |
| JardianceEmpagliflozin | 58 | $87,561 |
| EliquisApixaban | 57 | $61,827 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $33,975 |
| TrulicityDulaglutide | 14 | $26,674 |
| FarxigaDapagliflozin Propanediol | 14 | $13,396 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $10,784 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 39 | $9,011 |
| Humulin NInsulin Nph Human Isophane | 42 | $6,345 |
| Gabapentin | 227 | $4,615 |
| Atorvastatin Calcium | 375 | $3,386 |
| Humulin N KwikpenInsulin Nph Human Isophane | 12 | $3,247 |
| Naratriptan Hcl | 11 | $3,115 |
| Humulin RInsulin Regular, Human | 31 | $2,851 |
| Wixela InhubFluticasone Propion/Salmeterol | 26 | $2,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $279 | $145,204119 claims |
| Boehringer IngelheimJardiance | $132 | $87,56158 claims |
| PfizerEliquis | $44 | $61,82757 claims |
| Lilly USA, LLCTrulicity, Humulin 70-30, Humulin N | $93 | $42,03095 claims |
| GSKTrelegy Ellipta | $35 | $33,97524 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $76 | $24,18025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Tucson
- Robert MutterperlTucson$5.3M
- Nebojsa SkrepnikTucson$4.7M
- Franz RischardTucson$3.7M
- Girish KaramchandaniTucson$2.9M
- Siddharth SinghalTucson$1.3M
- Rajesh JanardhananTucson$983K
- Carl DienerTucson$750K
- Roxana RodriguezTucson$547K
- Mona SelejTucson$440K
- Muhammad HusnainTucson$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.